Rating History for Nautilus Biotechnology (NAUT) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/27/2026 | Subbu Nambi | Maintain | Buy (N/A) |
4.00 (2.50) |
|
Details | |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/27/2026 | Subbu Nambi | Maintain | Buy (N/A) |
4.00 (2.50) |
|
Details | |
![]() |
|||||||
![]() |
|||||||